|
基石药业, 02616.HK - 综合现金流量表 |
2022-12 |
2021-12 |
2020-12 |
2019-12 |
2018-12 |
2017-12 |
2016-12 |
经营活动之现金流量 |
-612,469 |
-1,484,024 |
-508,070 |
-1,080,722 |
-791,107 |
-240,186 |
-213,006 |
投资回报及融资费用之现金流量 |
-2,136 |
7,450 |
21,543 |
38,915 |
5,111 |
5,754 |
44 |
已收利息 |
9,672 |
9,692 |
22,863 |
39,218 |
5,111 |
6,054 |
44 |
已付利息 |
-11,808 |
-2,242 |
-1,320 |
-303 |
0 |
-300 |
0 |
已收股息 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
已付股息 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
其他 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
退回/(已缴)税项 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
投资活动之现金流量 |
355,447 |
-836,244 |
1,157,869 |
-698,102 |
-382,812 |
262,246 |
-753,513 |
增添固定资产 |
0 |
-85,900 |
-31,628 |
-6,213 |
-7,012 |
-12,130 |
-1,101 |
出售固定资产 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
投资增加 |
0 |
-190,297 |
0 |
-34,065 |
-286,360 |
-3,743,048 |
-767,879 |
投资减少 |
69,391 |
10,125 |
8,482 |
121,795 |
664,666 |
4,017,661 |
15,390 |
与关联人士之现金流量 |
0 |
0 |
0 |
0 |
-307,219 |
0 |
304,029 |
其他 |
286,056 |
-570,172 |
1,181,015 |
-779,619 |
-446,887 |
-237 |
-303,952 |
融资活动前之现金流量 |
-259,158 |
-2,312,818 |
671,342 |
-1,739,909 |
-1,168,808 |
27,814 |
-966,475 |
融资活动之现金流量 |
40,275 |
94,546 |
1,390,749 |
2,091,635 |
1,662,420 |
0 |
1,010,503 |
新增贷款 |
113,042 |
96,215 |
58,582 |
0 |
0 |
0 |
0 |
偿还贷款 |
-75,296 |
-18,499 |
-6,961 |
-4,683 |
0 |
0 |
0 |
定息/债项工具融资 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
偿还定息/债项工具 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
股本融资 |
2,529 |
16,830 |
1,360,928 |
2,096,318 |
1,969,639 |
0 |
706,474 |
与关联人士之现金流量 |
0 |
0 |
0 |
0 |
-307,219 |
0 |
304,029 |
其他 |
0 |
0 |
-21,800 |
0 |
0 |
0 |
0 |
现金及等同现金之增加/(减少) |
-218,883 |
-2,218,272 |
2,062,091 |
351,726 |
493,612 |
27,814 |
44,028 |
年初之现金及现金等同项目 |
742,724 |
3,024,548 |
1,126,436 |
701,336 |
83,390 |
59,539 |
15,511 |
外汇兑换率变动之影响/(其他) |
34,843 |
-63,552 |
-163,979 |
73,374 |
124,334 |
-3,963 |
0 |
年终之现金及现金等同项目 |
558,684 |
742,724 |
3,024,548 |
1,126,436 |
701,336 |
83,390 |
59,539 |
货币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
单位 |
核数师意见 |
1 |
1 |
1 |
1 |
1 |
0 |
0 |
说明:1代表无保留意见;2代表保留意见;3代表修改意见
|
|